XBiotech Inc. (XBIT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    XBiotech Inc.

    NASDAQ: XBIT · Real-Time Price · USD
    2.69
    -0.09 (-3.24%)
    At close: Sep 25, 2025, 3:59 PM
    2.74
    1.86%
    After-hours: Sep 25, 2025, 06:54 PM EDT

    XBiotech Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a 4.01M 18.39M
    Cost of Revenue
    		 n/a 1.74M 651K 5.82M
    Gross Profit
    		 n/a -1.74M 3.36M 12.57M
    Operating Income
    		 -42.47M -37.51M -34.49M -25.08M
    Interest Income
    		 9.81M 10.42M 3.82M 467K
    Pretax Income
    		 -38.56M -24.31M -33.59M -25.46M
    Net Income
    		 -38.53M -24.56M -32.9M -17.41M
    Selling & General & Admin
    		 4.71M 4.66M 6.3M 9.39M
    Research & Development
    		 37.76M 32.85M 31.54M 28.27M
    Other Expenses
    		 n/a n/a -121K -132K
    Operating Expenses
    		 42.47M 37.51M 37.85M 37.66M
    Interest Expense
    		 807K n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 42.47M 37.51M 38.5M 43.48M
    Income Tax Expense
    		 -32K 244K -688K -8.04M
    Shares Outstanding (Basic)
    		 30.46M 30.32M 30.44M 30.04M
    Shares Outstanding (Diluted)
    		 30.46M 30.44M 30.44M 30.04M
    EPS (Basic)
    		 -1.26 -0.81 -1.08 -0.58
    EPS (Diluted)
    		 -1.26 -0.81 -1.08 -0.58
    EBITDA
    		 -36.01M -35.77M -31.88M -22.43M
    EBIT
    		 -39.37M -37.51M -34.49M -25.08M
    Depreciation & Amortization
    		 1.75M 1.74M 2.61M 2.65M

    Add to Watchlist